The Use of Genomic Tests for Identifying Patients with Early Stage ILC Who Will Benefit from Chemo
Follow
Lobular Breast Cancer Alliance Advisory Board member Dr. Otto Metzger discusses the latest research looking at Oncotype and what it could mean for early stage ILC patients in the future.